Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.47%KO-0.71%0700.HK-6.35%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.84%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.70%0857.HK-2.43%UNH-10.21%1288.HK-1.71%PM-0.85%0005.HK-2.16%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.69%AUDUSD-1.59%EURAUD+1.01%AUDCAD-1.00%AUDCHF-1.00%GBPAUD+0.95%AUDNZD-0.95%NZDJPY-0.77%GBPJPY-0.75%EURJPY-0.72%CADJPY-0.70%CHFJPY-0.70%AUDSGD-0.64%NZDUSD-0.64%GBPUSD-0.62%USDCHF+0.62%USDCAD+0.60%EURUSD-0.59%AUDDKK-0.57%USDZAR+0.48%GBPTRY+0.41%AUDNOK-0.40%USDMXN+0.39%NZDMXN+0.35%USDTHB+0.32%GBPHKD+0.32%EURZAR+0.32%USDNOK+0.31%GBPZAR+0.30%GBPMXN-0.28%CHFNOK+0.24%NOKJPY-0.23%USDSEK+0.22%USDTRY+0.21%USDPLN+0.20%EURCNH-0.18%EURNOK+0.16%EURHKD-0.16%USDILS+0.16%CHFSEK+0.15%USDDKK+0.15%USDJPY-0.13%USDCNH-0.12%PLNJPY-0.10%GBPSGD-0.09%EURSGD-0.08%EURSEK+0.08%USDSGD+0.07%NZDCAD-0.07%EURPLN+0.05%NZDCHF-0.05%GBPCAD-0.05%EURNZD+0.05%EURGBP+0.05%NZDSGD+0.04%USDCOP-0.04%EURCZK+0.04%SGDJPY+0.03%EURCHF+0.03%CADCHF+0.02%USDHKD-0.02%GBPNZD+0.02%GBPCHF-0.01%CHFSGD-0.01%EURCAD0.00%EURDKK0.00%XPTUSD-1.03%XAGUSD-0.70%GAGUSD-0.70%HG1-0.63%W1-0.55%GAUUSD-0.52%XAUUSD-0.52%XNGUSD-0.42%C1-0.40%S1-0.18%UKOIL+0.17%USOIL-0.12%BTCUSD-3.42%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.77%ZECUSDT-6.76%XMRUSDT-2.10%DOGEUSD+55.95%LINKUSD-3.24%XLMUSD-3.75%BCHUSDT-3.45%LTCUSD+47.50%UNIUSD-2.84%SUIUSD-2.88%TONUSD+59.18%HBARUSDT-5.17%TAOUSDT-3.05%AAVEUSD-3.31%ONDOUSDT-5.19%ICPUSDT-2.22%DOTUSDT-3.76%WLDUSDT-3.57%ARBUSDT-5.51%ATOMUSDT-2.31%INJUSDT-7.34%STXUSDT-3.10%PYTHUSDT-0.66%TIAUSDT-3.10%FETUSDT-4.54%JUPUSDT-0.13%SEIUSDT-4.48%GRTUSDT-3.25%OPUSDT-3.90%IOTAUSDT-2.39%POLUSDT-1.98%WIFUSDT-2.98%AXSUSDT-2.76%EOSUSDT-4.24%IMXUSDT-3.36%FARTCOINUSDT-6.86%GALAUSDT-2.38%DYDXUSDT-2.73%ORDIUSDT-2.46%NOTUSDT-2.34%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.47%KO-0.71%0700.HK-6.35%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.84%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.70%0857.HK-2.43%UNH-10.21%1288.HK-1.71%PM-0.85%0005.HK-2.16%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.69%AUDUSD-1.59%EURAUD+1.01%AUDCAD-1.00%AUDCHF-1.00%GBPAUD+0.95%AUDNZD-0.95%NZDJPY-0.77%GBPJPY-0.75%EURJPY-0.72%CADJPY-0.70%CHFJPY-0.70%AUDSGD-0.64%NZDUSD-0.64%GBPUSD-0.62%USDCHF+0.62%USDCAD+0.60%EURUSD-0.59%AUDDKK-0.57%USDZAR+0.48%GBPTRY+0.41%AUDNOK-0.40%USDMXN+0.39%NZDMXN+0.35%USDTHB+0.32%GBPHKD+0.32%EURZAR+0.32%USDNOK+0.31%GBPZAR+0.30%GBPMXN-0.28%CHFNOK+0.24%NOKJPY-0.23%USDSEK+0.22%USDTRY+0.21%USDPLN+0.20%EURCNH-0.18%EURNOK+0.16%EURHKD-0.16%USDILS+0.16%CHFSEK+0.15%USDDKK+0.15%USDJPY-0.13%USDCNH-0.12%PLNJPY-0.10%GBPSGD-0.09%EURSGD-0.08%EURSEK+0.08%USDSGD+0.07%NZDCAD-0.07%EURPLN+0.05%NZDCHF-0.05%GBPCAD-0.05%EURNZD+0.05%EURGBP+0.05%NZDSGD+0.04%USDCOP-0.04%EURCZK+0.04%SGDJPY+0.03%EURCHF+0.03%CADCHF+0.02%USDHKD-0.02%GBPNZD+0.02%GBPCHF-0.01%CHFSGD-0.01%EURCAD0.00%EURDKK0.00%XPTUSD-1.03%XAGUSD-0.70%GAGUSD-0.70%HG1-0.63%W1-0.55%GAUUSD-0.52%XAUUSD-0.52%XNGUSD-0.42%C1-0.40%S1-0.18%UKOIL+0.17%USOIL-0.12%BTCUSD-3.42%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.77%ZECUSDT-6.76%XMRUSDT-2.10%DOGEUSD+55.95%LINKUSD-3.24%XLMUSD-3.75%BCHUSDT-3.45%LTCUSD+47.50%UNIUSD-2.84%SUIUSD-2.88%TONUSD+59.18%HBARUSDT-5.17%TAOUSDT-3.05%AAVEUSD-3.31%ONDOUSDT-5.19%ICPUSDT-2.22%DOTUSDT-3.76%WLDUSDT-3.57%ARBUSDT-5.51%ATOMUSDT-2.31%INJUSDT-7.34%STXUSDT-3.10%PYTHUSDT-0.66%TIAUSDT-3.10%FETUSDT-4.54%JUPUSDT-0.13%SEIUSDT-4.48%GRTUSDT-3.25%OPUSDT-3.90%IOTAUSDT-2.39%POLUSDT-1.98%WIFUSDT-2.98%AXSUSDT-2.76%EOSUSDT-4.24%IMXUSDT-3.36%FARTCOINUSDT-6.86%GALAUSDT-2.38%DYDXUSDT-2.73%ORDIUSDT-2.46%NOTUSDT-2.34%RONINUSDT-2.92%
EP

Eton Pharmaceuticals, Inc. (ETON)

NASDAQ • Healthcare

$61.99
-$1.65 (-2.6%)
Market closed

Last close at November 18, 2026 at 21:00 UTC

Open$63.75
Day Range$61.43 - $64.63
Avg. Volume (3M)614K
Market Cap$1.7B
P/E Ratio35.0
52 Week Range
$14.27$70.64

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$57.9M100%
Gross Profitminus cost of goods$44.3M76%
Operating Incomeminus R&D and overhead$23M40%
Net Incomeminus taxes and the rest$35.2M61%

In plain terms: out of every $100 in revenue, Eton Pharmaceuticals, Inc. keeps $61 as net profit.

Fundamentals & Financials

Revenue (TTM)
$141M
Net Income (TTM)
$49.8M
EPS (TTM)
$1.77
ROA (TTM)
31.71%
Current Ratio
1.79
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-50.0%Q2 2026$0.05
+84.4%Q3 2026$0.35
+60.0%Q4 2026$0.5

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +60.0%

Revenue rose year over year for Eton Pharmaceuticals in the third fiscal quarter of 2026, based on preliminary results reported November 5, 2026, with revenue of about $57.9 million reflecting continued contributions from its marketed rare-disease medicines across endocrine, metabolic, and liver-related disorders. Cash generation was a key feature of the quarter, with operating cash flow of roughly $35.2 million. For the next period, consensus calls for EPS of $0.38 on revenue of $45.9 million.

View full earnings history

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) develops and commercializes rare-disease medicines as a specialty pharmaceutical company, with $80.0 million in FY2025 revenue. Its marketed portfolio spans endocrine, metabolic, and liver-related disorders, and includes products for severe primary IGF-1 deficiency, adrenal disorders, Wilson disease, phenylketonuria, homocystinuria, and tyrosinemia type 1.

Name
Eton Pharmaceuticals, Inc.
CEO
Sean E. Brynjelsen
Industry
Healthcare
Year Founded
2017
Employees
44

Today's Snapshot

AI-generated

The day ended with ETON 2.6% lower at 61.99, in line with a weaker sector. Volume was about half of its usual level.

Trading Volume

Below 10d avg (870.9K)

471.9K

vs S&P 500 Today

Underperforming Market

-2.35%

Updated: November 18, 2026 at 21:14 UTC

Technical Indicators

6 Buy2 Neutral0 Sell
ETON’s setup is bullish with several confirmations across trend, momentum and breadth despite elevated volatility. ADX shows a running trend, momentum indicators including MACD and a positive short-term momentum reading favor buyers, and the price sits comfortably above short-, medium- and long-term moving averages including the 200-day, which is a broad sign of strength. On-balance volume is supportive even though ATR indicates above-average volatility, and the classic pivot sits slightly above the market. Technical takeaway: Strong Buy—broad trend and momentum alignment underpin a bullish stance while volatility is elevated.
All signals
  • EMA (5 indicators)$39.48 - $61.37
    Buy
  • RSI (14)57.80
    Neutral
  • Stochastic %K (14, 3, 3)68.37
    Neutral
  • MACD Level (12, 26)2.93
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.